Join Illumina at ESHG 2026 to explore how the latest advances in genomics are helping researchers move from insight to real‑world impact, faster and with greater confidence.
From long‑range genomic insights to end‑to‑end workflows, Illumina solutions are designed to support you at every stage of discovery.
At ESHG 2026, you can:
Hear from early adopters as they share how proximity mapped read technology is delivering deeper genomic insights without the complexity of traditional long‑read sequencing.
Welcome
Sean Humphray, PhD
Sr. Director Clinical R&D, Illumina
Data to insights: advancing bioinformatics for long-range genomic
James Han
Vice President Bioinformatics, Illumina
Long-range genomic insights: experience and perspective
Marcel Nelen, PhD
Head of Genome Diagnostic Section, Clinical Genetics Laboratory Specialist, Genetics Dept, UMC Utrecht
Insights into NHS paediatric acute care pathways
Prof. Emma Baple
Royal Devon University Healthcare NHS Foundation Trust, University of Exeter
Martina Owens
Royal Devon University Healthcare NHS Foundation Trust
Through real‑world examples, learn how integrated multiomics is addressing complex biological questions, what is possible today, what´s next, and how integration of different modalities accelerates discovery and impact.
Illumina’s multiomics roadmap – The path from insight to impact
Cande Rogert, PhD
VP Global Head of Advanced Science, Illumina
Applying Multiomics in Transplantation research
Brendan Keating
Member of the Faculty, Department of Surgery, New York University
A Retrospective Comparison of Illumina 5‑Base Sequencing on Matched Samples for Methylation Analysis of CNS Tumors
Matt Loose
Professor of Developmental and Computational Biology, Faculty of Medicine & Health Sciences, University of Nottingham
A 200 million cell genome-wide perturb-seq atlas with CRISPRi, CRISPRa, and siRNA
Martijn Vochteloo, PhD
Sr Bioinformatician R&D, Illumina
Proteogenomics of Complex Disease: Integrating pQTLs, SomaScan Proteomics, and Multi-Omics Networks to Resolve Genetic Risk in COPD and Beyond
Russell Bowler, Cleveland Clinic
Attend presentations on innovative technology at our Corporate Presentation sessions in the Sequencing Square, Exhibition Hall
A clinical-grade multimodal sequencing platform (GEUS) for Genomic and Epigenomic Profiling: Insights from CLL
Ester Cuenca-Leon
Business Development, Aniling
Human genetics developers for the diagnosis of hemoglobinopathies
Dr. C.L. Harteveld
Leiden University Medical Center
Hologenomic profiling: A mechanistic approach for detecting colorectal disease
Daniel Wise
Origin Sciences
Interested in a free trial of Illumina’s analysis software? Visit our booth and schedule a demo to discover end‑to‑end bioinformatics solutions that take you from sample to insight—supporting genetic diseases, population‑scale screening projects, oncology, and multiomics.
Connect with our representatives at the booth to learn how we can partner to maximize the potential of your data, how to streamline your workflows, scale and fuel your next breakthrough. Additionally, you can also request one-to-one meeting with our Senior Leadership by speaking with your local Illumina contact.
Visit our booth to learn more about the posters and presentations we are participating in.